Maryland Senators File Measure to Offer Veterans Free Access to Psychedelics

February 17, 2022 10:15:51

Earlier this week, a group of senators in the state of Maryland filed a measure which would establish a fund that could be used to support research into the therapeutic potential of psychedelics. The bill also called for providing free access to psychedelic drugs such as ketamine, MDMA and psilocybin for military veterans with PTSD.

The bill, which was sponsored by Sen. Sarah Elfreth, would create a PTSD Alternative Therapies fund. The state fund would finance studies on psychedelics through Maryland’s Department of Health as well as offer cost-free access to alternative therapies.

The measure stipulates that regulators will have to regularly consult with the Department of Veterans Affairs, the Walter Reed National Military Medical Center, Sheppard Pratt, the University of Maryland and the Johns Hopkins University on the use of psychedelic substances for post-traumatic stress disorder.

It also indicates reporting requirements that may be used to come up with legislations on providing regulated access to psychedelic drugs for therapeutic use in the future. In addition, the bill stipulates that the state’s Department of Health will have to submit a report to the governor and legislature with initial recommendations and findings by Dec. 1, 2022. Another deadline for recommendations and findings on research funded through the Post Traumatic Stress Disorder Alternative Therapies fund is set for two years later.

The measure, which has nine senators as cosponsors, notes that the report must include findings on the effectiveness of the use of alternative therapies as PTSD treatments, as well as recommendations on regulatory, legislative or budgetary changes to increase access to alternative therapies for military veterans with PTSD. The measure is set to receive a hearing in the Budget and Taxation Committee on March 2, 2022.

This legislation is the latest example of how the psychedelic reform movement is growing in the country, following a number of successful campaigns to decriminalize entheogenic fungi and plants in a number of state legislatures. For example, in Oklahoma two GOP legislators filed two measures, one of which would further decriminalize low-level possession of psilocybin while the other would promote research into the therapeutic potential of this particular psychedelic.

Soon after this, a House committee in the state of Utah approved a measure that would establish a task force to conduct research on psychedelic drugs and make recommendations on possible regulations for their legal use. Additionally, a legislator in Missouri introduced a measure last month that would give residents in the state with severe ailments legal access to various psychedelic drugs, under the state’s right-to-try law.

As more jurisdictions enact laws allowing the regulated use of psychedelic medicine, sector companies such as Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) will have a wider market to serve.

NOTE TO INVESTORS: The latest news and updates relating to Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are available in the company’s newsroom at

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published:

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork.